{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T09:50:32Z","timestamp":1714729832307},"reference-count":28,"publisher":"Wiley","issue":"S51","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":7084,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1989,12]]},"abstract":"<jats:p>A number of antigens (Ags) are expressed on normal and malignant terminal B (plasma) cells, including plasma\u2010cell, earlier B\u2010cell, and non\u2010B cell\u2010Ags. These Ags, coupled with indirect and dual fluorochrome labelling techniques, permit characterization of normal and malignant in vitro and in vivo terminal B\u2010cell differentiation. The majority (90%) of B cells within spleen bear B1 and lack PCA\u20101 Ags. As B cells differentiate to pokeweed mitogen in vitro, immunoglobulin (Ig) secretion precedes the appearance of cell surface PCA\u20101 and plasmacytoid morphology. Dual fluorescence cell sorting permits characterization of in vivo B\u2010cell differentiation: B1 + PCA\u20101 + cells are more \u201cdifferentiated\u201d since they are more prevalent in lymph node than spleen, exhibit plasmacytoid morphology and maximal Ig secretion, and no longer respond to triggers of B\u2010cell proliferation; in contrast, B1 + PCA\u20101\u2010 cells are lymphoid in morphology and may respond to triggers of B\u2010cell proliferation as \u201cresting\u201d B cells. Similar studies of myeloma cells demonstrated that they may also include cells expressing plasma\u2010cell, earlier B, and non\u2010B cell Ags. Although they neither proliferated nor secreted Ig in vitro to G\/M\u2010CSF, G\u2010CSF, M\u2010CSF, IL\u20101, IL\u20101B, IL\u20102, or IL\u20104, proliferation without Ig secretion (Stimulation Index \u2265 3.0) was induced to IL\u20106 in 6 of 10 patients (pts); to IL\u20103 (2 pts) and to IL\u20105 (2 pts). Myeloma cells which proliferated to the greatest extent to IL\u20106 have plasmablast morphology and appear to express an earlier B\u2010cell phenotype (B4\u00b1CALLA\u00b1B1 + PCA\u20101 \u00b1) than those cells which either did not or only weakly responded (B4\u2010CALLA \u2010B1\u00b1PCA \u20101\u00b1). Phenotypic definition of growth factor\u2010responsive myeloma cells may both facilitate their biological characterization in vitro and permit enhanced understanding of aberrant B\u2010cell differentiation in vivo.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1989.tb01487.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T17:07:26Z","timestamp":1279472846000},"page":"19-26","source":"Crossref","is-referenced-by-count":4,"title":["Phenotypic and functional characterization of normal and malignant terminal B (plasma) cells"],"prefix":"10.1111","volume":"43","author":[{"given":"Kenneth C.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Cochran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce A.","family":"Barut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"303","volume-title":"Leucocyte Typing III White Cell Differentiation Antigens","author":"Ling NR","year":"1987"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V63.6.1424.1424"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.4049\/jimmunol.134.3.1516","article-title":"Studies of in vitro activation and differentiation of human B lymphocytes I. Phenotypic and functional characterization of the B cell population responding to anti\u2010Ig antibody","volume":"134","author":"Boyd AW","year":"1985","journal-title":"J Immunol"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.130.3.1132"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1986.tb04084.x"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1986.tb02902.x"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112968"},{"key":"e_1_2_1_9_2","first-page":"185","article-title":"Reactivity of the B cell blind panel with plasma cell neoplasms","volume":"33","author":"Hamilton MS","year":"1989","journal-title":"Tissue Antigens"},{"key":"e_1_2_1_10_2","first-page":"188","article-title":"Immunohistological evaluation of plasma cell reactivity of the workshop B cell panel antibodies","volume":"33","author":"Thaler J","year":"1989","journal-title":"Tissue Antigens"},{"key":"e_1_2_1_11_2","first-page":"180","article-title":"Elevation of B\u2010cell\/plasma cell associated CD antigens in the peripheral blood of multiple myeloma (MM) patients","volume":"33","author":"Pilkington GR","year":"1989","journal-title":"Tissue Antigens"},{"key":"e_1_2_1_12_2","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1182\/blood.V70.5.1482.1482","article-title":"Elimination of clonogenic stem cells from human multiple myeloma cell lines by a plasma cell\u2010reactive monoclonal antibody and complement","volume":"70","author":"Tong AW","year":"1987","journal-title":"Blood"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V70.4.932.932"},{"key":"e_1_2_1_14_2","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1182\/blood.V72.4.1248.1248","article-title":"Elimination of myeloma cells from bone marrow using monoclonal antibodies and immunobeads","volume":"72","author":"Shimazaki C","year":"1988","journal-title":"Blood"},{"key":"e_1_2_1_15_2","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1182\/blood.V71.4.861.861","article-title":"Phenotypic heterogeneity in aneuploid multiple myeloma indicates pre\u2010B cell involvment","volume":"71","author":"Epstein J","year":"1988","journal-title":"Blood"},{"key":"e_1_2_1_16_2","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1182\/blood.V73.3.763.763","article-title":"Myelomonocytic antigen positive multiple myeloma","volume":"73","author":"Grogan TM","year":"1989","journal-title":"Blood"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.150.4.792"},{"key":"e_1_2_1_18_2","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.4049\/jimmunol.122.6.2413","article-title":"Shared idiotypes on human peripheral blood B and T lymphocytes","volume":"122","author":"Lea T","year":"1979","journal-title":"J Immunol"},{"key":"e_1_2_1_19_2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0308-2261(21)00322-2","article-title":"Idiotype\u2010bearing lymphoid cells in plasma cell neoplasia","volume":"11","author":"Mellstedt H","year":"1982","journal-title":"Clin Haematol"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112080"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(80)90072-0"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.126.4.1435"},{"key":"e_1_2_1_23_2","doi-asserted-by":"crossref","first-page":"820","DOI":"10.4049\/jimmunol.134.2.820","article-title":"Isolation and functional analysis of human B cell populations. I. Characterization of the B1 + B2 + and B1 + B2 \u2014 subsets","volume":"134","author":"Anderson KC","year":"1985","journal-title":"J Immunol"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(83)90222-3"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111794"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(84)90001-8"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V73.7.1915.1915"},{"key":"e_1_2_1_28_2","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.4049\/jimmunol.136.10.3612","article-title":"Dual fluorochrome analysis of human B lymphocytes: phenotypic examination of resting, anti\u2010immuno\u2010globulin stimulated, and in vivo activated B cells","volume":"136","author":"Anderson KC","year":"1986","journal-title":"J Immunol"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V65.3.620.620"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1989.tb01487.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1989.tb01487.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T05:24:42Z","timestamp":1697952282000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1989.tb01487.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,12]]},"references-count":28,"journal-issue":{"issue":"S51","published-print":{"date-parts":[[1989,12]]}},"alternative-id":["10.1111\/j.1600-0609.1989.tb01487.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1989.tb01487.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,12]]}}}